| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
| RE49918 | Cytotoxic benzodiazepine derivatives | May 10, 21 | Apr 16, 24 | Immunogen Inc. |
| RE49834 | Jak1 selective inhibitors and uses thereof | Nov 15, 21 | Feb 13, 24 | Hangzhou Highlightll Pharmaceutical Co., Ltd. |
| RE49698 | Substituted dihydroquinazolines | Jul 21, 20 | Oct 17, 23 | AIC246 AG & Co. KG |
| RE49579 | Non-peptidic GAPDH aggregation inhibitor | Nov 24, 20 | Jul 18, 23 | University Public Corporation Osaka |
| RE49129 | Method of treatment of hypoxia inducible factor (HIF)-related conditions | Jun 27, 19 | Jul 12, 22 | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| RE48635 | ERK inhibitors | May 22, 19 | Jul 13, 21 | Eli Lilly and Company |
| RE48557 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Aug 27, 19 | May 18, 21 | The Regents of the University of Colorado a Body Corporate |
| RE48239 | Heteroaryl pyridone and aza-pyridone compounds | Oct 30, 18 | Oct 06, 20 | Genetech, Inc. |
| RE48183 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Aug 28, 18 | Sep 01, 20 | Santen Pharmaceutical Co. Ltd. |
| RE47528 | Protease for wound conditioning and skin care | Jan 25, 18 | Jul 23, 19 | B.R.A.I.N. Biotechnology Research and Information Network AG |
| RE47451 | Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases | Oct 13, 17 | Jun 25, 19 | Hanmi Pharm. Co. Ltd. |
| RE47115 | Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis | Aug 05, 16 | Nov 06, 18 | Ferring B.V.; Brookhaven Science Associates, LLC; |
| RE47080 | Chemical amplification based on fluid partitioning | Jan 31, 17 | Oct 09, 18 | Lawrence Livermore National Security, LLC |
| 9999619 | Piperidin-4-yl azetidine derivatives as JAK1 inhibitors | Oct 07, 16 | Jun 19, 18 | Incyte Holdings Corporation; Incyte Corporation; |
| 9994613 | Prodrug of an ICE inhibitor | Oct 07, 16 | Jun 12, 18 | Vertex Pharmaceuticals Incorporated |
| 9994559 | Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists | Dec 16, 15 | Jun 12, 18 | King's College London |
| 9993524 | Prophylactic or therapeutic agent for hepatic diseases | Apr 26, 13 | Jun 12, 18 | Not available |
| 9993516 | Treatment of left ventricular non-compaction and dilated cardiomyopathy by inhibiting melanocortin receptor four | Nov 19, 14 | Jun 12, 18 | The Brigham and Women's Hospital Inc. |
| 9994528 | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use | Aug 11, 15 | Jun 12, 18 | Cytokinetics, Inc. |